Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03307733
Other study ID # STH19365
Secondary ID
Status Completed
Phase N/A
First received August 23, 2017
Last updated October 6, 2017
Start date September 1, 2016
Est. completion date July 1, 2017

Study information

Verified date October 2017
Source Sheffield Hallam University
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

A physical activity feasibility randomised control trial for pregnant, obese women.


Description:

Overweight (defined as BMI ≥25kg/m2) and obesity (defined as BMI ≥30kg/m2) during pregnancy is becoming more common. Approximately 25-30% of women of childbearing age are obese and around 50% are overweight at the time of conception. Women who are either overweight or obese have a much higher risk of adverse pregnancy outcomes. For example, they are more likely to develop gestational diabetes, pregnancy-induced hypertension, pre-eclampsia, Caesarean section and other complications. Recent research suggests that overweight and obese pregnant women are less active than normal weight ( BMI≤ 25kg/m2) pregnant women and also that the level of physical activity decreases throughout pregnancy. The evidence also suggests that maintaining a good level of physical activity can reduce the risks of adverse pregnancy outcomes. A large study which looked at the most preferred types of physical activity identified that walking and swimming were the most preferred types of physical activity by pregnant women. Although there is an association between walking at a brisk pace and a reduced risk of gestational diabetes, there is no definitive conclusion on the effectiveness of walking interventions. The investigators are proposing this feasibility study in order to find out whether a walking intervention can be implemented during pregnancy in the obese population to reduce adverse pregnancy health outcomes. The current study will investigate whether a Fitibit Pedometer and a Social networking Site (Facebook) can be used to encourage pregnant, obese women to increase and maintain activity during pregnancy. The feasibility study will test the recruitment strategy, acceptability of the intervention design, randomisation acceptability, and timing of the intervention. Participants from both the control and the intervention will be purposefully selected to take part in focus group following the intervention in order to give feedback on the study. The investigators will be working with an Obstetrics & Gynaecology consultant at Jessop Wing, Hallamshire Hospital to help with the recruitment process and provide clinical advice. Women who are obese (BMI>30kg/m2) in their early pregnancy (12-14 weeks) will be recruited. Participants that consent to take part in the study will be given a Fitbit pedometer and enrolled in a closed Facebook group. Each participant will wear a Fitbit for a week in order to measure their baseline physical activity level. Thereafter, the participants in the intervention will be asked to gradually increase their physical activity level (they will be given a weekly step target)for 4 weeks in total. The Facebook component of the intervention will contain motivational and educational posts and rewarding messages about their progress. The control group will be asked to wear a Fitbit for 5 weeks and do their usual activities in total with a covered screen so as to not see the step count


Recruitment information / eligibility

Status Completed
Enrollment 40
Est. completion date July 1, 2017
Est. primary completion date July 1, 2017
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Female
Age group 18 Years and older
Eligibility Inclusion Criteria:

- pregnant 11-14 weeks gestation

- BMI >30kg/m2

- No known risks or complications

- Able to walk

Exclusion Criteria:

- High risk of miscarriage

Study Design


Related Conditions & MeSH terms


Intervention

Behavioral:
walking and behavour change techniques
a Fitbit pedometer with individualised step targets and partaking in a closed Facebook group

Locations

Country Name City State
n/a

Sponsors (1)

Lead Sponsor Collaborator
Sheffield Hallam University

Outcome

Type Measure Description Time frame Safety issue
Primary Recruitment Recruitment rate will be calculated by simple descriptive statistics. (number of participants approached vs. number of participants that agree to take part) 5 weeks
Primary Compliance Compliance to the study procedures will be calculated by simple descriptive. statistics 5 weeks
Primary Attrition Drop out rate will be calculated by simple descriptive statistics. 5 weeks
Primary Adherence rates Adherence to Fitbit will be measured daily. 5 weeks
Secondary Gestational Weight Gain Women are recruited at 11-14 weeks gestation and after 5 weeks when they are at 20 weeks gestation the final assessments will be collected. Weight is measured in kilograms. 5 weeks
Secondary gestational diabetes status Outcome of the gestational diabetes mellitus test at 26 weeks gestation. 26 weeks
Secondary Pregnancy and Birth outcomes Preeclampsia ( Percentage figure of patients who developed preeclampsia during birth will be calculated from clinical notes). 9 months
Secondary C-section Mode of Delivery ( Number of participants from each group who have a C-section will be calculated) 9 months
Secondary Birth weight Weight of the baby at birth. This data will be collected from clinical notes. At delivery ( 9 months roughly)
Secondary Apgar score 5 minute Apgar Score. Score data will be collected from clinical notes. At delivery ( 9 months roughly)
See also
  Status Clinical Trial Phase
Recruiting NCT04991402 - Obesogenic Origins of Maternal and Child Metabolic Health Involving Dolutegravir
Active, not recruiting NCT02766426 - Cytokine and Body Composition's Changes in Overweight/Obese Women N/A